We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:
Medicine & public health

Search Results

Showing 1-20 of 2,142 results

  1. Hairy Cell Leukemia: Where Are We in 2023?

    Purpose of Review

    This article summarizes the current state of knowledge of hairy cell leukemia (HCL) regarding presentation, diagnosis, therapy, and...

    Andres Mendez-Hernandez, Krishna Moturi, ... Leslie A. Andritsos in Current Oncology Reports
    Article Open access 25 April 2023

  2. Genetic Variations in Hairy Cell Leukemia with Brain Involvement: Case Report

    Hairy cell leukemia (HCL) is an infrequent neoplasm of mature B cells with rare neurologic involvement. These patients typically present with...

    Tessa Harland, Mahmoud Aldyab, ... Robert S. Heller in SN Comprehensive Clinical Medicine
    Article 09 August 2023

  3. Advances in the Treatment of Hairy Cell Leukemia Variant

    Hairy cell leukemia variant (HCL-V) is a rare B cell lymphoproliferative disorder with a clinical-pathological distinction from the classic form of...

    Julie Tran, Charles Gaulin, Martin S. Tallman in Current Treatment Options in Oncology
    Article 01 January 2022

  4. BRAF inhibitor treatment of classical hairy cell leukemia allows successful vaccination against SARS-CoV-2

    In classical hairy cell leukemia (HCL), standard treatments including purine analogs achieve a durable response (up to 90%), but lead to severe...

    Judith Konrat, Wiebke Rösler, ... Thorsten Zenz in Annals of Hematology
    Article Open access 10 December 2022

  5. Hairy cell leukemia: a specific 17-gene expression signature points to new targets for therapy

    Background

    Hairy cell leukemia (HCL) is a rare chronic B cell malignancy, characterized by infiltration of bone marrow, blood and spleen by typical...

    Elsa Maitre, Edouard Cornet, ... Thomas Matthes in Journal of Cancer Research and Clinical Oncology
    Article Open access 27 April 2022

  7. Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances

    Purpose of Review

    This article aims to bring an update on the recent discoveries in hairy cell leukemia (HCL), especially findings in pathophysiology...

    Jérôme Paillassa, Elsa Maitre, Xavier Troussard in Current Oncology Reports
    Article 11 April 2022

  8. Purine nucleoside analogs plus rituximab are an effective treatment choice for hairy cell leukemia-variant

    Both characteristics and optimal treatment strategy for hairy cell leukemia-variant (HCL-v) remain elusive due to its rarity. We retrospectively...

    Yi Wang, Tingyu Wang, ... Shuhua Yi in Annals of Hematology
    Article 18 April 2022

  10. Long-term outcomes of elderly hairy cell leukemia patients treated with cladribine

    Hairy cell leukemia (HCL) is a rare hematologic disorder characterized by pancytopenia and splenomegaly for which a single course of cladribine is...

    David J. Hermel, Brian Cheng, ... Alan Saven in Annals of Hematology
    Article 26 February 2022

  12. Skin changes in hairy cell leukemia

    Skin lesions have been reported in about 10–12% of hairy cell leukemia (HCL) patients. Most are etiologically related to autoimmune or infectious...

    Ewa Robak, Dorota Jesionek-Kupnicka, Tadeusz Robak in Annals of Hematology
    Article Open access 20 November 2020

  13. Hairy cell leukemia and COVID-19 adaptation of treatment guidelines

    Standard treatment options in classic HCL (cHCL) result in high response rates and near normal life expectancy. However, the disease itself and the...

    Michael Grever, Leslie Andritsos, ... Bernhard Wörmann in Leukemia
    Article Open access 04 May 2021

  14. The genomic landscape and clonal evolutionary trajectory of classical hairy cell leukemia

    Luz Yurany Moreno Rueda, Dean Bryant, ... Surinder S. Sahota in Leukemia
    Article Open access 28 January 2023

  15. B-cell prolymphocytic leukemia: an enduring bona fide entity

    B-cell prolymphocytic leukemia (B-PLL) was recognized as a distinct entity in the fourth edition of the World Health Organization (WHO)...

    Miguel S. Gonzalez-Mancera, Jean Lopategui, ... Serhan Alkan in International Journal of Hematology
    Article 26 May 2024

  16. Successful treatment of hairy cell leukemia variant with obinutuzumab

    Diana Al-Sarayfi, Freek O. Meeuwes, ... Marcel Nijland in Annals of Hematology
    Article Open access 04 June 2021

  17. Attack of the clones: a T-cell population resembling adult T-cell leukemia/lymphoma, and large granular lymphocytosis, in an HTLV-2-infected patient

    The HTLV-1 and HTLV-2 viruses, though closely genetically related, have divergent clinical impact: HTLV-1 has been causally linked with adult T-cell...

    Michael E. Kallen, Yoshine Saito, ... Rima Koka in Journal of Hematopathology
    Article 29 September 2022

  19. Biology and Treatment of Hairy Cell Leukemia

    Despite its rarity, hairy cell leukemia (HCL) remains a fascinating disease and the physiopathology is becoming more and more understood. The...

    Jérôme Paillassa, Xavier Troussard in Current Treatment Options in Oncology
    Article 30 April 2020

  20. The Utility of CD43 and CD200 in Differentiating Chronic Lymphocytic Leukemia from Other Mature B-Cell Neoplasms: A Cross Sectional Study

    To evaluate the utility of CD43 and CD200 in differentiating chronic lymphocytic leukemia (CLL) from other mature B-cell neoplasms. This was a...

    Narasimhapriyan Kannan, Jasmita Dass, ... Manoranjan Mahapatra in Indian Journal of Hematology and Blood Transfusion
    Article 30 November 2023
Did you find what you were looking for? Share feedback.